Advertisement

The Nutshell

» NIH, cancer and policy

Daily News Roundup

Most Recent

image: NIH Names New Extramural Research Head

NIH Names New Extramural Research Head

By | September 29, 2015

Michael Lauer, director of the National Heart Lung and Blood Institute’s Division of Cardiovascular Sciences, has worked for the National Institutes of Health since 2007.

0 Comments

image: Immunologist, AIDS Research Advocate Dies

Immunologist, AIDS Research Advocate Dies

By | September 24, 2015

William Paul, the National Institutes of Health’s Laboratory of Immunology chief, passed away at age 79.

0 Comments

image: NIMH Head Leaves

NIMH Head Leaves

By | September 16, 2015

Thomas Insel, the director for the National Institute of Mental Health, will work for Google Life Sciences on the prevention and detection of mental diseases.

0 Comments

image: Direct-to-Consumer Liquid Biopsy

Direct-to-Consumer Liquid Biopsy

By | September 13, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Tide Shifting on Embryo Gene Editing?

Tide Shifting on Embryo Gene Editing?

By | September 11, 2015

An international bioethics group says that research that involves editing genes in human embryos can be valuable, though it doesn’t approve of making “designer babies.”

0 Comments

image: Influential Cancer Biologist Dies

Influential Cancer Biologist Dies

By | August 24, 2015

Chris Marshall, who pieced together a critical signaling pathway involved in cancer, has passed away at age 66.

0 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: Vaccine Fraudster Gets Jail Time

Vaccine Fraudster Gets Jail Time

By | July 6, 2015

The researcher who spiked rabbit blood with human antibodies to make an HIV vaccine look more effective is sentenced to 57 months in prison and must repay his National Institutes of Health grant.

6 Comments

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Amyloid Thwarts Microbial Invaders
    Daily News Amyloid Thwarts Microbial Invaders

    Alzheimer’s disease–associated amyloid-β peptides trap microbes in the brains of mice and in the guts of nematodes, a study shows. 

Advertisement
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate